Chinese Journal of Pharmaceuticals
|
2025, 56(4): 552-558
• Pharmaceutical Management & Information •
Discussion on the MAH’s Quality System in the Case of Contract Cooperative Manufacturing of Biological Products
Full
Meng CAO
1, 2, Yin CHENG
1, Jiajing WANG
1, 2, Zhenglong DONG
1, 2, Xiangyu LI
1, 2, *
Affiliations
- 1.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201210
- 2.Collaborative Research Center for Drug Regulatory Science, ECNU-SCDEI, Shanghai 200241
Published: 2025-04-10
doi: 10.16522/j.cnki.cjph.2025.04.018
Outline
曹萌, 成殷, 王佳静, 董正龙, 李香玉.
生物制品分段委托生产情形下的持有人质量管理体系关注点探讨.
中国医药工业杂志,
2025
, 56
(4)
: 552
-558
.
DOI: 10.16522/j.cnki.cjph.2025.04.018
Meng CAO, Yin CHENG, Jiajing WANG, Zhenglong DONG, Xiangyu LI.
Discussion on the MAH’s Quality System in the Case of Contract Cooperative Manufacturing of Biological Products[J].
Chinese Journal of Pharmaceuticals,
2025
, 56
(4)
: 552
-558
.
DOI: 10.16522/j.cnki.cjph.2025.04.018
Year 2025 volume 56 Issue 4
58
23
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.04.018
- Receive Date:2024-11-20
- Online Date:2026-11-17
- Published:2025-04-10